Viral Myocarditis—From Pathophysiology to Treatment

The diagnosis of acute and chronic myocarditis remains a challenge for clinicians. Characterization of this disease has been hampered by its diverse etiologies and heterogeneous clinical presentations. Most cases of myocarditis are caused by infectious agents. Despite successful research in the last...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Heinz-Peter Schultheiss, Christian Baumeier, Ganna Aleshcheva, C.-Thomas Bock, Felicitas Escher
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/ade72ae2107b4e46b9ef1710fb83763d
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:ade72ae2107b4e46b9ef1710fb83763d
record_format dspace
spelling oai:doaj.org-article:ade72ae2107b4e46b9ef1710fb83763d2021-11-25T18:00:47ZViral Myocarditis—From Pathophysiology to Treatment10.3390/jcm102252402077-0383https://doaj.org/article/ade72ae2107b4e46b9ef1710fb83763d2021-11-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/22/5240https://doaj.org/toc/2077-0383The diagnosis of acute and chronic myocarditis remains a challenge for clinicians. Characterization of this disease has been hampered by its diverse etiologies and heterogeneous clinical presentations. Most cases of myocarditis are caused by infectious agents. Despite successful research in the last few years, the pathophysiology of viral myocarditis and its sequelae leading to severe heart failure with a poor prognosis is not fully understood and represents a significant public health issue globally. Most likely, at a certain point, besides viral persistence, several etiological types merge into a common pathogenic autoimmune process leading to chronic inflammation and tissue remodeling, ultimately resulting in the clinical phenotype of dilated cardiomyopathy. Understanding the underlying molecular mechanisms is necessary to assess the prognosis of patients and is fundamental to appropriate specific and personalized therapeutic strategies. To reach this clinical prerequisite, there is the need for advanced diagnostic tools, including an endomyocardial biopsy and guidelines to optimize the management of this disease. The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has currently led to the worst pandemic in a century and has awakened a special sensitivity throughout the world to viral infections. This work aims to summarize the pathophysiology of viral myocarditis, advanced diagnostic methods and the current state of treatment options.Heinz-Peter SchultheissChristian BaumeierGanna AleshchevaC.-Thomas BockFelicitas EscherMDPI AGarticleviral myocarditisautoimmunitydilated cardiomyopathypathophysiologyendomyocardial biopsytherapeutic approachMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5240, p 5240 (2021)
institution DOAJ
collection DOAJ
language EN
topic viral myocarditis
autoimmunity
dilated cardiomyopathy
pathophysiology
endomyocardial biopsy
therapeutic approach
Medicine
R
spellingShingle viral myocarditis
autoimmunity
dilated cardiomyopathy
pathophysiology
endomyocardial biopsy
therapeutic approach
Medicine
R
Heinz-Peter Schultheiss
Christian Baumeier
Ganna Aleshcheva
C.-Thomas Bock
Felicitas Escher
Viral Myocarditis—From Pathophysiology to Treatment
description The diagnosis of acute and chronic myocarditis remains a challenge for clinicians. Characterization of this disease has been hampered by its diverse etiologies and heterogeneous clinical presentations. Most cases of myocarditis are caused by infectious agents. Despite successful research in the last few years, the pathophysiology of viral myocarditis and its sequelae leading to severe heart failure with a poor prognosis is not fully understood and represents a significant public health issue globally. Most likely, at a certain point, besides viral persistence, several etiological types merge into a common pathogenic autoimmune process leading to chronic inflammation and tissue remodeling, ultimately resulting in the clinical phenotype of dilated cardiomyopathy. Understanding the underlying molecular mechanisms is necessary to assess the prognosis of patients and is fundamental to appropriate specific and personalized therapeutic strategies. To reach this clinical prerequisite, there is the need for advanced diagnostic tools, including an endomyocardial biopsy and guidelines to optimize the management of this disease. The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) has currently led to the worst pandemic in a century and has awakened a special sensitivity throughout the world to viral infections. This work aims to summarize the pathophysiology of viral myocarditis, advanced diagnostic methods and the current state of treatment options.
format article
author Heinz-Peter Schultheiss
Christian Baumeier
Ganna Aleshcheva
C.-Thomas Bock
Felicitas Escher
author_facet Heinz-Peter Schultheiss
Christian Baumeier
Ganna Aleshcheva
C.-Thomas Bock
Felicitas Escher
author_sort Heinz-Peter Schultheiss
title Viral Myocarditis—From Pathophysiology to Treatment
title_short Viral Myocarditis—From Pathophysiology to Treatment
title_full Viral Myocarditis—From Pathophysiology to Treatment
title_fullStr Viral Myocarditis—From Pathophysiology to Treatment
title_full_unstemmed Viral Myocarditis—From Pathophysiology to Treatment
title_sort viral myocarditis—from pathophysiology to treatment
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/ade72ae2107b4e46b9ef1710fb83763d
work_keys_str_mv AT heinzpeterschultheiss viralmyocarditisfrompathophysiologytotreatment
AT christianbaumeier viralmyocarditisfrompathophysiologytotreatment
AT gannaaleshcheva viralmyocarditisfrompathophysiologytotreatment
AT cthomasbock viralmyocarditisfrompathophysiologytotreatment
AT felicitasescher viralmyocarditisfrompathophysiologytotreatment
_version_ 1718411765402828800